Fig. 5From: The Patient, Investigator, Nurse, Carer Questionnaire (PINC-Q): a cross-sectional, retrospective, non-interventional study exploring the impact of less frequent medication administration with paliperidone palmitate 3-monthly as maintenance treatment for schizophreniaCommunication quality and frequency. Footnote: a Changes in communication quality following the switch from PP1M to PP3M. Stakeholders were asked ‘Has the quality of communication improved as a result of switching to PP3M?’. b Change in frequency of patient communication. Stakeholders were asked ‘As a result of switching to PP3M have you noticed any change in the frequency of communications between the patient and family members, friends and/or other people?’. PP3M, paliperidone palmitate 3-monthlyBack to article page